RAPT Therapeutics バランスシートの健全性
財務の健全性 基準チェック /56
RAPT Therapeuticsの総株主資本は$95.5M 、総負債は$0.0で、負債比率は0%となります。総資産と総負債はそれぞれ$108.5Mと$13.0Mです。
主要情報
0%
負債資本比率
US$0
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | US$97.91m |
| エクイティ | US$95.51m |
| 負債合計 | US$12.96m |
| 総資産 | US$108.47m |
財務の健全性に関する最新情報
Can RAPT Therapeutics (NASDAQ:RAPT) Afford To Invest In Growth?
Nov 10
Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky
Jun 13Is RAPT Therapeutics (NASDAQ:RAPT) In A Good Position To Invest In Growth?
Feb 21We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
Sep 12We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
May 10We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Feb 07Recent updates
Can RAPT Therapeutics (NASDAQ:RAPT) Afford To Invest In Growth?
Nov 10RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus
Jul 24Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky
Jun 13RAPT Therapeutics: Dip Following FDA Clinical Hold Creates Asymmetric Opportunity
May 20Is RAPT Therapeutics (NASDAQ:RAPT) In A Good Position To Invest In Growth?
Feb 21We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
Sep 12We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
May 10We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Feb 07We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Oct 12RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jan 25RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Oct 15RAPT Therapeutics (RAPT) skyrockets 100% on positive RPT193 data in early-stage atopic dermatitis study
Jun 14RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jun 08Should You Take Comfort From Insider Transactions At RAPT Therapeutics, Inc. (NASDAQ:RAPT)?
Mar 15We Think RAPT Therapeutics (NASDAQ:RAPT) Can Easily Afford To Drive Business Growth
Feb 15
RAPT Therapeutics' (NASDAQ:RAPT) Stock Price Has Reduced 56% In The Past Year
Jan 18RAPT Therapeutics: Interesting Asset, But Doubtful History And Bad Market Reaction
Jan 08Here's What RAPT Therapeutics, Inc.'s (NASDAQ:RAPT) Shareholder Ownership Structure Looks Like
Dec 21The Independent Chairman of the Board of RAPT Therapeutics, Inc. (NASDAQ:RAPT), William Rieflin, Just Bought 12% More Shares
Nov 23Earnings Beat: RAPT Therapeutics, Inc. (NASDAQ:RAPT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Nov 19財務状況分析
短期負債: RAPTの 短期資産 ( $102.6M ) が 短期負債 ( $10.4M ) を超えています。
長期負債: RAPTの短期資産 ( $102.6M ) が 長期負債 ( $2.6M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: RAPTは負債がありません。
負債の削減: RAPT過去 5 年間負債を抱えていません。
貸借対照表
キャッシュ・ランウェイ分析
過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。
安定したキャッシュランウェイ: RAPTは、現在の フリーキャッシュフロー に基づくと、キャッシュランウェイ が 1 年未満です。
キャッシュランウェイの予測: RAPTは、フリー キャッシュ フローが毎年22 % の歴史的率で減少し続ける場合、 1年間十分なキャッシュ ランウェイを有しています。